|
Name |
4-Hydroxy-1-methyl-2-quinolone
|
Molecular Formula | C10H9NO2 | |
IUPAC Name* |
4-hydroxy-1-methylquinolin-2-one
|
|
SMILES |
CN1C2=CC=CC=C2C(=CC1=O)O
|
|
InChI |
InChI=1S/C10H9NO2/c1-11-8-5-3-2-4-7(8)9(12)6-10(11)13/h2-6,12H,1H3
|
|
InChIKey |
RTNPPPQVXREFKX-UHFFFAOYSA-N
|
|
Synonyms |
4-Hydroxy-1-methyl-2-quinolone; 1677-46-9; 4-Hydroxy-1-methyl-2(1H)-quinolone; 4-hydroxy-1-methylquinolin-2(1H)-one; 4-Hydroxy-1-methylcarbostyril; 1-Methyl-4-hydroxycarbostyril; 2(1H)-Quinolinone, 4-hydroxy-1-methyl-; 4-Hydroxy-N-methylcarbostyril; 4-Hydroxy-1-methyl-2(1H)-quinolinone; CARBOSTYRIL, 4-HYDROXY-1-METHYL-; 1-Methyl-4-hydroxy-2-chinolon; 4-hydroxy-1-methylquinolin-2-one; N-Methyl-4-hydroxykarbostyril; 1-Methyl-4-hydroxy-2-chinolinon; NSC 39973; NSC39973; N-Methyl-4-hydroxykarbostyril [Czech]; 1-Methyl-4-hydroxy-2-chinolon [Czech]; V713CAW761; MFCD00024052; NSC-39973; 1-methyl-4-hydroxy-2(1H)-quinolinone; 4-HYDROXY-1-METHYL-1H-2-QUINOLINONE; N-Methyl-4-hydroxykarbostyril (CZECH); 1-Methyl-4-hydroxy-2-chinolon (CZECH); 4-hydroxy-1-methyl-1,2-dihydroquinolin-2-one; EINECS 216-830-3; 4-Hydroxy-1-methyl-1H-quinolin-2-one; 4-HYDROXY-N-METHYL-2-QUINOLONE; BRN 1528990; 1-Methyl-4-hydroxy-2-chinolinon [Czech]; 2(1H)-Quinolinone,4-hydroxy-1-methyl-; Maybridge1_002182; Oprea1_834130; 5-21-12-00311 (Beilstein Handbook Reference); SCHEMBL835056; UNII-V713CAW761; 4-Hydroxy-1-methyl carbostyril; CHEMBL2022051; DTXSID0061874; SCHEMBL13143143; 1-methyl-4-hydroxy-2-quinolone; HMS547L04; WLN: T66 BNVJ B1 EQ; n-methyl-4-hydroxy-2-quinolinone; 4-hydroxy-1-methyl-2-quinolinone; 4-hydroxy-1-methyl-quinolin-2-one; ALBB-019832; BBL036914; STK327478; STL514059; ZINC18190627; AKOS000121455; AKOS037491726; ZINC103644054; SDCCGMLS-0065887.P001; 1-methyl-4-hydroxyquinolin-2(1H)-one; 2-hydroxy-1-methylquinolin-4(1H)-one; N-METHYL-4-HYDROXYQUINOL-2-ONE; UPCMLD0ENAT5889157:001; 1-METHYL-4-HYDROXYQUINOLIN-2-ONE; 4-HYDROXY-N-METHYL-2-QUINOLINONE; NS-01441; DB-043712; CS-0131691; EU-0087440; FT-0618613; M1009; 4-Hydroxy-1-methyl-2(1H)-quinolone, 98%; 4-HYDROXY-1-METHYLQUINOLINE-2(1H)-ONE; AB00694265-02; A810900; W-109693; 1-METHYL-2-OXO-1,2-DIHYDRO-4-HYDROXYQUINOLINE
|
|
CAS | 1677-46-9 | |
PubChem CID | 54686436 | |
ChEMBL ID | CHEMBL2022051 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 175.18 | ALogp: | 0.9 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 40.5 | Aromatic Rings: | 2 |
Heavy Atoms: | 13 | QED Weighted: | 0.662 |
Caco-2 Permeability: | -4.763 | MDCK Permeability: | 0.00002330 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.011 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.013 |
30% Bioavailability (F30%): | 0.005 |
Blood-Brain-Barrier Penetration (BBB): | 0.905 | Plasma Protein Binding (PPB): | 83.44% |
Volume Distribution (VD): | 0.858 | Fu: | 10.49% |
CYP1A2-inhibitor: | 0.961 | CYP1A2-substrate: | 0.936 |
CYP2C19-inhibitor: | 0.185 | CYP2C19-substrate: | 0.542 |
CYP2C9-inhibitor: | 0.076 | CYP2C9-substrate: | 0.813 |
CYP2D6-inhibitor: | 0.034 | CYP2D6-substrate: | 0.821 |
CYP3A4-inhibitor: | 0.037 | CYP3A4-substrate: | 0.25 |
Clearance (CL): | 8.65 | Half-life (T1/2): | 0.642 |
hERG Blockers: | 0.012 | Human Hepatotoxicity (H-HT): | 0.089 |
Drug-inuced Liver Injury (DILI): | 0.11 | AMES Toxicity: | 0.792 |
Rat Oral Acute Toxicity: | 0.076 | Maximum Recommended Daily Dose: | 0.322 |
Skin Sensitization: | 0.625 | Carcinogencity: | 0.851 |
Eye Corrosion: | 0.044 | Eye Irritation: | 0.959 |
Respiratory Toxicity: | 0.799 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002806 | 0.522 | D06GKN | 0.356 | ||||
ENC002158 | 0.431 | D0K7WK | 0.356 | ||||
ENC001042 | 0.407 | D07HBX | 0.340 | ||||
ENC004686 | 0.394 | D06BYV | 0.339 | ||||
ENC004693 | 0.394 | D02WCI | 0.333 | ||||
ENC004684 | 0.382 | D03GET | 0.333 | ||||
ENC002793 | 0.382 | D08EOD | 0.328 | ||||
ENC000028 | 0.381 | D06DLI | 0.327 | ||||
ENC002566 | 0.379 | D06IXT | 0.323 | ||||
ENC001367 | 0.377 | D0B1FE | 0.317 |